Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-05-23
2006-05-23
Carlson, Karen Cochrane (Department: 1653)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07049418
ABSTRACT:
The present invention relates generally to therapeutic and diagnostic agents. More particularly, the present invention provides therapeutic molecules capable of modulating signal transduction such as but not limited to cytokine-mediated signal transduction. The molecules of the present invention are useful, therefore, in modulating cellular responsiveness to cytokines as well as other mediators of signal transduction such as endogenous or exogenous molecules, antigens, microbes and microbial products, viruses or components thereof, ions, hormones and parasites.
REFERENCES:
patent: 0 989 186 (2000-03-01), None
patent: WO 98/30688 (1998-07-01), None
patent: WO 99/03993 (1999-01-01), None
Accession No. Z47352, ID: MMPRMGNS (1995), XP-002165867 (Abstract).
Schlüter, G. et al., “Sequence Analysis of the Conserved Protamine Gene Cluster Shows That it Contains a Fourth Expressed Gene”,Molecular Reproduction and Development 43:1-6 (1996), XP-000993037.
Accession No. Z46940, ID: HSPRMTNP2 (1995), XP-002165868 (Abstract).
Accession No. Z46939; ID: BTPRMTNP2 (1995), XP-002165869 (Abstract).
Yoshimura, A. et al., “A Novel Cytokine-Inducible Gene CIS Encodes an SH2-Containing Protein that Binds to Tyrosine-Phosphorylated Interleukin 3 and Erythropoietin Receptors”,The EMBO Journal 14(12):2816-2826 (1995), XP-002088456.
Minamoto, S. et al., “Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3”,Biochemical and Biophysical Research Communications 237:79-83 (1997), XP-002095406.
Fu, X. et al., “E2a-Pbx1 Induces Aberrant Expression of Tissue-Specific and Developmentally Regulated Genes When Expressed in NIH 3T3 Fibroblasts”,Molecular and Cellular Biology 17(3):1503-1512 (1997),XP-002172402.
Starr, R et al., “A Family of Cytokine-Inducible Inhibitors of Signalling”,Nature 387:917-921 (1997), XP-002085491.
Endo, T.A. et al., “A New Protein Containing an SH2 Domain that Inhibits JAK Kinases”,Nature 387:921-924 (1997), XP-002085492.
Naka, T. et al., “Structure and Function of a New STAT-Inducted STAT Inhibitor”,Nature 387:924-928 (1997), XP-002088455.
Accession No. AA189608, ID: MMAA81160 (1997), XP-002172404 (Abstract).
Hilton, D.J. et al., “Twenty Proteins Containing a C-Terminal SOCS Box Form Five Structural Classes”,Proceedings of the National Academy of Sciences of USA 95:114-119 (1998), XP-002085497.
Watson et al., “Molecular Biology of the Gene”, 4thedition (1987).
Hilton et al., “Twenty Proteins Containing a C-Terminal SOCS Box Form Five Structural Classes”,Proc Natl. Acad Science USA 95:114-119 (1998).
Accession No. U72673, ID: MMU72673 (1997), XP-002172403 (Abstract).
W.S. Alexander et al. (1995) “Point Mutations Within a Dimer Interface Homology Domain of c-Mpl Induce Constitutive Receptor Activity and Tumorigenicity”The Embo Journal 14: 5569-5578.
S.F. Altschul et al. (1990) “Basic Local Alignment Search Tool”J. Mol. Biol. 215: 403-410.
J.F. Bazan (1990) “Haemopoietic Receptors and Helical Cytokines” Immunology Today 11 (10): 350-354.
R.L. Cutler et al. (1993) “Multiple Cytokines Induce the Tyrosine Phosphorylation of She and its Association With Grb2 . . ”The Journal of Biological Chemistry 268(20): 21463-21465.
J.E. Darnell, Jr. et al. (1984) “Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins”Science 264: 1415-1421.
M. David et al. (1995) “Requirement for MAP Kinase (ERK2) Activity in Interferon—alpha and Interferon—beta Stimulated Gene Expression Through STAT Proteins”Science 269: 1721-1723.
M. David et al. (1996) “STAT Activation by Epidermal Growth Factor (EGF) and Amphiregulin”The Journal of Biological Chemistry 271(16): 9185-9188.
A. Dugaiczyk et al. (1983) “Cloning and Sequencing of a Deoxyribonucleic Acid Copy of Glyceraldehyde-3-phosphate Dehydrogenase Messenger Ribonucleic Acid . . . ”Biochemistry 22: 1605-1613.
J.E. Durbin et al. (1996) “Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease”Cell 84: 443-450.
T. Etzold et al. (1996) “SRS: Information Retrieval System for Molecular Biology Data Banks”Methods in Enzymoloogy 266: 114-128.
S. Gupta et al. (1996) “The SH2 Domains of Stat1 and Stat2 Mediate Multiple Interactions in the Transduction of IFN- Signals”The EMBO Journal 15(5): 1075-1084.
D.J. Hilton (1994) “An Introduction to Cytokine Receptors”Guidebook to Cytokines and Their ReceptorsOxford, England: Oxford University Press.
D.J. Hilton et al. (1994) “Cloning of a Murine IL-II Receptor -chain; Requirement for gp130 for High Affinity Binding and Signal Transduction”The EMBO Journal 13(20): 4765-4775.
D.J. Hilton et al. (1996) “Saturation Mutagenesis of the WSXWS Motif of the Erythropoietin Receptor*”The Journal of Biological Chemistry 271(9): 4699-4708.
Y. Ichikawa (1969) “Differentiation of a Cell Line of Myeloid Leukemia”J. Cell. Physiol. 74: 223-234.
JN. Ihle (1995) “Cytokine Receptor Signalling”Nature 377: 591-594.
M.H. Kaplan et al. (1996) “Stat6 is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells”Immunity 4: 313-319.
M.H. Kaplan et al. (1996) “Impaired IL-12 Responses and Enhanced Development of Th2 Cells in Stat4-deficient Mice”Nature 382: 174-179.
D.W. Leaman et al. (1996) “Roles of JAKs in Activation of STATs and Stimulation of c-fos Gene Expression by Epidermal Growth Factor”Mollecular and Cellular Biology 16(1): 369-375.
M.A. Meraz et al. (1996) “Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK-STAT Signaling Pathway”Cell 84: 431-442.
S. Mizushima and S. Nagata (1990) “pEF-BOS, A Powerful Mammalian Expression Vector”Nucleic Acids Research 18(17): 5322.
M. Murakami et al. (1991) “Critical Cytoplasmic Region of the Interleukin 6 Signal Transducer gp130 is Conserved in the Cytokine Receptor Family”Proc. Nat'l. Acad. Sci. USA 88: 11349-11353.
E.J. Neer et al. (1994) “The Ancient Regulatory-protein Family of WD-repeat Proteins”Nature 371: 297-300.
N.A. Nicola et al. (1996) “Molecular Cloning of Two Novel Transmembrane Ligands for Eph-related Kinases (LERKS) That Are Related to LERK-2”Growth Factors 13: 141-149.
U. Novak et al. (1995) “Colony-stimulating Factor 1-Induced STAT1 and STAT3 Activation Is Accompanied by Phosphorylation of Tyk2 in Macrophages and Tyk2 and JAK1 in Fibroblasts”Blood 86(8): 2948-2956.
W.R. Pearson et al. (1988) “Improved Tools for Biological Sequence Comparison”Proc. Nat'l. Acad. Sci. USA 85: 2444-2448.
W.R. Pearson (1990) “Rapid and Sensitive Sequence Comparison With FASTP and FASTA”Methods in Enzymology 183: 63-99.
J.R. Rayner and T.J. Gonda (1994) “A Simple and Efficient Procedure for Generating Stable Expression Libraries by cDNA in a Retroviral Vector”Molecular and Cellular Biology 14(2): 880-887.
N. Sato et al. (1993) “Signal Transduction by the High-affinity GM-CSF Receptor: Two Distinct Cytoplasmic Regions of the Common B-Subunit Responsible for Different Signaling”The EMBO Journal 12(11): 4181-4189.
K. Shimoda et al. (1996) “Lack of IL-4-induced Th2 Response and IgE Class Switching in Mice With Disrupted Stat6 Gene”Nature 380: 630-633.
K. Shual et al. (1993) “Polypeptide Signalling to the Nucleus Through Tyrosine Phosphorylation of Jak and Stat Proteins”Nature 366: 580-583.
S.R. Sprang et al. (1993) “Cytokine Structure Taxonomy and Mechanisms for Receptor Engagement”Current Opinion in Structural Biology 3: 815-827.
K. Takeda et al. (1996) “Essential Role of Stat6 in IL-4 Signalling”
Alexander Warren S.
Hilton Douglas J.
Metcalf Donald
Nicholson Sandra E.
Nicola Nicos A.
Carlson Karen Cochrane
Scully Scott Murphy & Presser
The Walter and Eliza Hall Institute of Medical Research
LandOfFree
Therapeutic and diagnostic agents comprising a SOCS box does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic and diagnostic agents comprising a SOCS box, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic and diagnostic agents comprising a SOCS box will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3537537